WO2012147106A3 - Compositions comprising extracts or fractions derived from annona squamosa for the prevention, treatment or control of inflammatory and metabolic disorders - Google Patents

Compositions comprising extracts or fractions derived from annona squamosa for the prevention, treatment or control of inflammatory and metabolic disorders Download PDF

Info

Publication number
WO2012147106A3
WO2012147106A3 PCT/IN2012/000313 IN2012000313W WO2012147106A3 WO 2012147106 A3 WO2012147106 A3 WO 2012147106A3 IN 2012000313 W IN2012000313 W IN 2012000313W WO 2012147106 A3 WO2012147106 A3 WO 2012147106A3
Authority
WO
WIPO (PCT)
Prior art keywords
metabolic disorders
prevention
treatment
extracts
inflammatory
Prior art date
Application number
PCT/IN2012/000313
Other languages
French (fr)
Other versions
WO2012147106A2 (en
Inventor
Ganga Raju Gokaraju
Rama Raju Gokaraju
Venkata Kanaka Ranga Raju Gokaraju
Trimurtulu Golakoti
Kiran Bhupathiraju
Venkata Krishna Raju Alluri
Krishanu Sengupta
Original Assignee
Laila Nutraceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laila Nutraceuticals filed Critical Laila Nutraceuticals
Publication of WO2012147106A2 publication Critical patent/WO2012147106A2/en
Publication of WO2012147106A3 publication Critical patent/WO2012147106A3/en
Priority to US14/065,583 priority Critical patent/US20140056987A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/19—Acanthaceae (Acanthus family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses synergistic composition comprising at least one Annona squamosa derived component standardized to acetogenin compound(s) having α,β- unsaturated-y-methyl-y-lactone moiety in combination with at least one biologically active ingredient derived from plants, animals or microorganisms such as vitamins, amino acids, minerals, fibers, various plant and herbal extracts for the prevention, treatment, inhibition or controlling inflammation and/or metabolic disorders and other associated or related diseases. The invention further discloses the method of treating inflammation and/or metabolic disorders and other associated or related diseases.
PCT/IN2012/000313 2011-04-29 2012-04-27 Compositions comprising extracts or fractions derived from annona squamosa for the prevention, treatment or control of inflammatory and metabolic disorders WO2012147106A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/065,583 US20140056987A1 (en) 2011-04-29 2013-10-29 Compositions comprising extracts or fractions derived from annona squamosa for the prevention, treatment or control of inflammatory and metabolic disorders

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1482/CHE/2011 2011-04-29
IN1482CH2011 2011-04-29

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US13/450,124 Continuation-In-Part US9427425B2 (en) 2009-10-19 2012-04-18 Extracts, fractions and compositions comprising acetogenins and their applications

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/065,583 Continuation-In-Part US20140056987A1 (en) 2011-04-29 2013-10-29 Compositions comprising extracts or fractions derived from annona squamosa for the prevention, treatment or control of inflammatory and metabolic disorders

Publications (2)

Publication Number Publication Date
WO2012147106A2 WO2012147106A2 (en) 2012-11-01
WO2012147106A3 true WO2012147106A3 (en) 2013-03-21

Family

ID=47072837

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2012/000313 WO2012147106A2 (en) 2011-04-29 2012-04-27 Compositions comprising extracts or fractions derived from annona squamosa for the prevention, treatment or control of inflammatory and metabolic disorders

Country Status (1)

Country Link
WO (1) WO2012147106A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112016018085B1 (en) * 2014-02-05 2021-11-03 Laila Nutraceuticals SYNERGIC DIETARY SUPPLEMENT COMPOSITIONS FOR THE PREVENTION, TREATMENT OR CONTROL OF INFLAMMATORY DISEASES AND THE RESPECTIVE METHOD OF APPLICATION OF SYNERGIC COMPOSITIONS

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991818B2 (en) * 2001-03-30 2006-01-31 Council Of Scientific & Industrial Research Compound iso-squamocin obtained from seeds of annona squamosa and composition containing the same
US20090298941A1 (en) * 2008-06-03 2009-12-03 Laila Impex Anti-adipocyte fatty acid-binding protein (ap2), anti-flap and anti-cyslt1 receptor herbal compositions
WO2011048617A2 (en) * 2009-10-19 2011-04-28 Laila Nutraceuticals Extracts, fractions and compositions comprising acetogenins and their applications

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991818B2 (en) * 2001-03-30 2006-01-31 Council Of Scientific & Industrial Research Compound iso-squamocin obtained from seeds of annona squamosa and composition containing the same
US20090298941A1 (en) * 2008-06-03 2009-12-03 Laila Impex Anti-adipocyte fatty acid-binding protein (ap2), anti-flap and anti-cyslt1 receptor herbal compositions
WO2011048617A2 (en) * 2009-10-19 2011-04-28 Laila Nutraceuticals Extracts, fractions and compositions comprising acetogenins and their applications

Also Published As

Publication number Publication date
WO2012147106A2 (en) 2012-11-01

Similar Documents

Publication Publication Date Title
CL2008000725A1 (en) Compounds derived from aromatic heterocycles; pharmaceutical composition; farm kit; use of the composition and compounds as glucan synthase inhibitors for the treatment or prevention of the growth of fungal pathogens in plants and to treat or prevent fungal infections.
NZ742943A (en) Compositions comprising a biological control agent and a fungicide from the group consisting of inhibitors of the respiratory chain at complex i or ii
EP3318128A3 (en) Composition comprising a biological control agent and a fungicide
WO2012145651A3 (en) Compounds for the treatment of neuropsychiatric disorders
NZ729290A (en) Composition containing a mixture of plant extracts or a mixture of molecules contained in said plants, and use for controlling carbohydrate and/or lipid metabolism
WO2008116129A3 (en) Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitors
MY160249A (en) Fatty acid fumarate derivatives and their uses
BRPI0513464A (en) fungicidal compositions
DE602007012133D1 (en) TRIAZOLOPYRIDINE COMPOUNDS FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
WO2007112453A3 (en) Methods amd compositions for treating conditions
WO2008157425A3 (en) Compounds for inhibiting protein aggregation, and methods for making and using them
WO2009117387A3 (en) Methods to treat neurodegenerative conditions or diseases by targeting components of a pten signaling pathway
MX2010009314A (en) Polyphenols for the treatment of cartilage disorders.
WO2008004224A3 (en) Synergistic compositions for crohn's disease and inflammatory gastrointestinal disorders
WO2012106058A3 (en) Animal treatments
WO2017020874A3 (en) Method for treating diseases in plants
WO2009012472A3 (en) Methods and compositions for treating conditions
WO2016186349A3 (en) Composition, containing quisaqualis indica extract, for preventing or treating prostatic hyperplasia
WO2013100718A3 (en) Pharmaceutical composition for preventing or treating inflammatory diseases or asthma, containing lagerstroemia ovalifolia extract or fraction thereof as active ingredient
PL1981517T3 (en) Herbal composition
WO2012147106A3 (en) Compositions comprising extracts or fractions derived from annona squamosa for the prevention, treatment or control of inflammatory and metabolic disorders
MX2010004513A (en) A standardized plant extract, process for obtaining the same and uses thereof.
MX2022002414A (en) Pathogenic control compositions and methods.
BR112012015590A2 (en) "composition and method for controlling plant diseases"
MX2010009315A (en) Nutritional compositions for promotion of bone growth and maintenance of bone health comprising extracts of for example rosemary or caraway.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12776136

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12776136

Country of ref document: EP

Kind code of ref document: A2